Delivery Order 36F79724D0159-36C26025F0209
Award Date
7/21/25
Potential Completion Date
7/20/26
Potential Value
$194K
Federal Agency
Veterans Integrated Service Network 20
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bartlett, TN 38134, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $187,679.82, was issued by the Department of Veterans Affairs (VA) to Actelion Pharmaceuticals US, Inc., a for-profit pharmaceutical manufacturer. The contract is for the delivery of a 12-month supply of the medication Uptravi, a treatment for pulmonary arterial hypertension. The contract is a delivery order under Actelion's existing Federal Supply Schedule (FSS-61-IB) contract with the VA, which has a ceiling value of $219,108,390 and runs from August 2024...
This is a federal contract award to Actelion Pharmaceuticals US, Inc., a for-profit pharmaceutical manufacturer, to provide Uptravi (selexipag) and other pulmonary arterial hypertension treatments to the Department of Veterans Affairs (VA) and Federal Bureau of Prisons. The contract, valued at $412,749.22, was awarded on October 1, 2024 and will run through September 30, 2025. This order was placed against Actelion's existing Federal Supply Schedule (FSS-61-IB) contract for Pharmaceuticals and...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a $224,845.70 delivery order contract to Actelion Pharmaceuticals US, Inc., a for-profit manufacturer of pharmaceutical products, to supply the drug UPTRAVI. This order is placed against Actelion's $105 million Federal Supply Schedule (FSS-61-IB) contract for Pharmaceuticals and Drugs, as well as a separate $60 million Blanket Purchase Agreement focused on pulmonary arterial hypertension therapies. Actelion, which...
This is a delivery order awarded by the Veterans Integrated Service Network 20 (VISN 20), part of the U.S. Department of Veterans Affairs (VA), to Actelion Pharmaceuticals US, Inc., a large pharmaceutical manufacturer. The $258,434 firm fixed-price contract is for the drug Uptravi, a therapy for pulmonary arterial hypertension. The contract is issued under Actelion's Federal Supply Schedule (FSS-61-IB) contract with the VA for Pharmaceuticals and Drugs, which has a total ceiling value of...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a $135,836.37 delivery order contract for the pharmaceutical product UPTRAVI to Actelion Pharmaceuticals US, Inc., a for-profit manufacturer of specialized drug therapies, including treatments for pulmonary arterial hypertension. This order is placed against Actelion's $105 million Federal Supply Schedule (FSS-61-IB) contract for Pharmaceuticals and Drugs, as well as a separate $60 million Blanket Purchase...
This is a Delivery Order awarded by the Department of Veterans Affairs (VA) to Actelion Pharmaceuticals US, Inc., a for-profit manufacturer of pharmaceutical products specializing in treatments for pulmonary arterial hypertension and other rare diseases. The contract is for the supply of Uptravi 16MCG (Selexipag) under Actelion's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The contract has a ceiling value of $142,249.86 and a period of performance ending...
The Department of Veterans Affairs Veterans Health Administration awarded a $172,113.18 firm fixed-price delivery order to Actelion Pharmaceuticals US, Inc. for 12 doses of Uptravi 1000 mcg tablets (generic selexipag). This order was placed against Actelion's 5-year, $105 million Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB), which allows federal agencies to procure needed prescription medications at pre-negotiated pricing. No set-aside designation was used for...
This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Actelion Pharmaceuticals US, Inc., a for-profit manufacturer of pharmaceuticals and specialty drug therapies. The $132,282.00 delivery order is funded through the VA's Veterans Integrated Service Network 12 and provides Actelion's pulmonary arterial hypertension medications, including Opsumit, Uptravi, Tracleer, and Ventavis, to VA healthcare facilities and federal...
This is a delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, awarded by the Department of Veterans Affairs Veterans Health Administration to Actelion Pharmaceuticals US, Inc., a for-profit manufacturer of pharmaceutical products. The $132,176.76 delivery order is for the drug Uptravi 1600MCG TABS, a treatment for pulmonary arterial hypertension. Actelion Pharmaceuticals holds a $105 million FSS contract and a $60 million Blanket Purchase...
This is a delivery order awarded by the Veterans Integrated Service Network 20 (VISN 20) of the U.S. Department of Veterans Affairs (VA) to Actelion Pharmaceuticals US, Inc., a pharmaceutical manufacturer. The contract is for the supply of UPTRAVI 200MCG and UPTRAVI 200MCG- 800MCG TITRATION PACK, which are treatments for pulmonary arterial hypertension. The award has a ceiling value of $84,086.52 and is a firm fixed-price contract. This delivery order is part of a larger Indefinite Delivery...